ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,841Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 103

$489K Total Retail Price of All Prescriptions

Rank: 37 out of 103

334 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 8,525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 562 454 1 3
WARFARIN SODIUM 366 330 2 7
AMLODIPINE BESYLATE 357 331 3 6
FUROSEMIDE 320 258 4 4
SIMVASTATIN 314 274 5 2
LISINOPRIL 309 273 6 5
HYDROCODONE-ACETAMINOPHEN 290 161 S3 7 11
LEVOTHYROXINE SODIUM 263 224 8 1
LOVASTATIN 245 245 9 67
ATENOLOL 234 196 10 14
METOPROLOL TARTRATE 185 165 11 9
FLUTICASONE PROPIONATE 178 125 12 35
TRAMADOL HCL 173 95 13 17
METOPROLOL SUCCINATE 162 145 14 8
POTASSIUM CHLORIDE 160 136 15 10
GABAPENTIN 157 63 16 22
PREDNISONE 156 120 17 24
GLIMEPIRIDE 148 130 18 50
HYDROCHLOROTHIAZIDE 147 129 19 16
CITALOPRAM HBR 146 139 20 15
METFORMIN HCL ER 144 133 21 70
LOSARTAN POTASSIUM 136 133 22 12
AZITHROMYCIN 121 75 23 44
MELOXICAM 115 88 24 49
LEVOFLOXACIN 111 92 25 57
FENTANYL 111 32 S2 25 34
PROAIR HFA 106 51 27 116
ALBUTEROL SULFATE 99 99 28 68
ATORVASTATIN CALCIUM 97 74 29 18
DONEPEZIL HCL 90 90 30 28
POLYETHYLENE GLYCOL 3350 87 77 31 31
ZOLPIDEM TARTRATE 87 54 31 29
DIGOXIN 83 81 33 25
IPRATROPIUM BROMIDE 72 72 34 128
METFORMIN HCL 72 58 34 13
GEMFIBROZIL 71 60 36 62
KLOR-CON M20 69 57 37 56
MORPHINE SULFATE ER 66 29 S2 38 145
OXYCODONE HCL 65 0 S2 39 85
FENOFIBRATE 63 39 40 58
ADVAIR DISKUS 63 54 40 42
GLIPIZIDE XL 62 38 42 120
TAMSULOSIN HCL 59 39 43 23
CRESTOR 56 56 44 27
NEXIUM 54 49 45 43
ACETAMINOPHEN-CODEINE 53 51 S3 46 122
NOVOLIN N 52 45 47 168
MIRTAZAPINE 52 51 47 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.